1. Home
  2. PHVS vs SAFE Comparison

PHVS vs SAFE Comparison

Compare PHVS & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • SAFE
  • Stock Information
  • Founded
  • PHVS 2015
  • SAFE 2016
  • Country
  • PHVS Switzerland
  • SAFE United States
  • Employees
  • PHVS N/A
  • SAFE N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • SAFE Real Estate Investment Trusts
  • Sector
  • PHVS Health Care
  • SAFE Real Estate
  • Exchange
  • PHVS Nasdaq
  • SAFE Nasdaq
  • Market Cap
  • PHVS 1.3B
  • SAFE 1.2B
  • IPO Year
  • PHVS 2021
  • SAFE 2017
  • Fundamental
  • Price
  • PHVS $24.30
  • SAFE $16.62
  • Analyst Decision
  • PHVS Strong Buy
  • SAFE Buy
  • Analyst Count
  • PHVS 5
  • SAFE 9
  • Target Price
  • PHVS $35.60
  • SAFE $21.78
  • AVG Volume (30 Days)
  • PHVS 123.2K
  • SAFE 343.6K
  • Earning Date
  • PHVS 11-12-2025
  • SAFE 10-27-2025
  • Dividend Yield
  • PHVS N/A
  • SAFE 4.29%
  • EPS Growth
  • PHVS N/A
  • SAFE N/A
  • EPS
  • PHVS N/A
  • SAFE 1.43
  • Revenue
  • PHVS N/A
  • SAFE $393,596,000.00
  • Revenue This Year
  • PHVS N/A
  • SAFE $0.59
  • Revenue Next Year
  • PHVS N/A
  • SAFE $5.06
  • P/E Ratio
  • PHVS N/A
  • SAFE $11.55
  • Revenue Growth
  • PHVS N/A
  • SAFE 2.22
  • 52 Week Low
  • PHVS $11.51
  • SAFE $13.43
  • 52 Week High
  • PHVS $26.33
  • SAFE $28.80
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 59.77
  • SAFE 59.68
  • Support Level
  • PHVS $23.20
  • SAFE $16.06
  • Resistance Level
  • PHVS $24.75
  • SAFE $17.16
  • Average True Range (ATR)
  • PHVS 1.29
  • SAFE 0.51
  • MACD
  • PHVS 0.07
  • SAFE -0.01
  • Stochastic Oscillator
  • PHVS 84.81
  • SAFE 61.89

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About SAFE Safehold Inc. New

Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.

Share on Social Networks: